The Choice of Vasopressor to Prevent Postoperative Acute Kidney Injury After Major Non-Cardiac Surgery (VEGA-2)
Norepinephrine vs Phenylephrine as the First-line Vasopressor to Prevent Postoperative Acute Kidney Injury After Major Non-cardiac Surgery
Sponsor: Duke University
This PHASE4 trial investigates Acute Kidney Injury (AKI) and Anesthesia and is currently actively recruiting participants. Duke University leads this study, which shows 4 recorded versions since 2025 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.
Status Flow
Change History
4 versions recorded-
Mar 2026 — Present [monthly]
Recruiting PHASE4
-
May 2025 — Mar 2026 [monthly]
Recruiting PHASE4
Status: Not Yet Recruiting → Recruiting
-
Mar 2025 — May 2025 [monthly]
Not Yet Recruiting PHASE4
-
Feb 2025 — Mar 2025 [monthly]
Not Yet Recruiting PHASE4
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Duke University
- Henry Ford Health System
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- University of California, San Francisco
- University of Maryland
- University of Michigan
- University of Texas Southwestern Medical Center
- University of Virginia
- University of Washington
- Wake Forest University Health Sciences
For direct contact, visit the study record on ClinicalTrials.gov .